Documents & Downloads
You may order paper copies by contacting ProFunds Client Services at 866-PRO-5125 (866-776-5125)
About the Fund
Investor Class
- Ticker PHPIX
- CUSIP 743185423
- Fund Number 47
- NAV (as of 11/20/2024) $27.17
- NAV Change $0.22 ( 0.82%)
Service Class
- Ticker PHPSX
- CUSIP 743185415
- Fund Number 77
- NAV (as of 11/20/2024) $22.32
- NAV Change $0.18 (0.81%)
Details
- Inception Date 6/28/2000
- Fund Group UltraSector ProFunds
- Limits on Exchanges None
- Minimum Investment (Individual) $15,000
- Minimum Investment (Financial Professional) $5,000
- Gross Expense Ratio 2.21%
- Net Expense Ratio* 1.78%
Investor Class
- Ticker PHPIX
- CUSIP 743185423
- Fund Number 47
- NAV (as of 11/20/2024) $27.17
- NAV Change $0.22 (0.82%)
Service Class
- Ticker PHPSX
- CUSIP 743185415
- Fund Number 77
- NAV (as of 11/20/2024) $22.32
- NAV Change $0.18 (0.81%)
Details
- Inception Date 6/28/2000
- Fund Group UltraSector ProFunds
- Limits on Exchanges None
- Minimum Investment (Individual) $15,000
- Minimum Investment (Financial Professional) $5,000
- Gross Expense Ratio 2.21%
- Net Expense Ratio* 1.78%
*Contractual waiver effective from December 1, 2023 through November 30, 2024. Without such a waiver of fees, the total returns may have been lower.
All data, unless otherwise noted, is for Investor Class Shares only and is subject to change.
Total Return
| Fund | 1m | 3m | YTD | 1Y | 3Y | 5Y | 10Y | Since Inception | Gross Expense Ratio (%) |
Net Expense Ratio |
Inception Date |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Pharmaceuticals UltraSector ProFund | 5.03% | 8.48% | 12.84% | 40.50% | -0.76% | 6.78% | 3.71% | 2.60% | 2.21% | 1.78% | 06/28/2000 |
| Fund | 1m | 3m | YTD | 1Y | 3Y | 5Y | 10Y | Since Inception | Gross Expense Ratio (%) |
Net Expense Ratio |
Inception Date |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Pharmaceuticals UltraSector ProFund | -0.97% | 16.48% | 7.44% | 13.78% | -1.09% | 7.04% | 3.53% | 2.40% | 2.21% | 1.78% | 06/28/2000 |
| Fund | 1m | 3m | YTD | 1Y | 3Y | 5Y | 10Y | Since Inception | Gross Expense Ratio (%) |
Net Expense Ratio |
Inception Date |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Pharmaceuticals UltraSector ProFund | 4.92% | 8.15% | 11.81% | 38.98% | -1.76% | 5.71% | 2.67% | 1.60% | 3.21% | 2.78% | 06/28/2000 |
| Fund | 1m | 3m | YTD | 1Y | 3Y | 5Y | 10Y | Since Inception | Gross Expense Ratio (%) |
Net Expense Ratio |
Inception Date |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Pharmaceuticals UltraSector ProFund | -1.09% | 16.12% | 6.57% | 12.58% | -2.07% | 5.97% | 2.49% | 1.41% | 3.21% | 2.78% | 06/28/2000 |
Past performance does not guarantee future results. The performance data quoted represents past performance and current returns may be lower or higher. The investment return and principal value of an investment will fluctuate so that an investor's shares, when redeemed, may be worth more or less than the original cost.
Index
as of 9/30/2024
- Total Number of Companies45
- Price/Earnings Ratio21.67
- Price/Book Ratio2.85
- Dividend Yield ( % )1.51
- Avg. Index Market Capitalization$44.32 billion
S&P Pharmaceuticals Select Industry Index
The Index represents the pharmaceuticals segment of the S&P Total Market Index (“S&P TMI”). The S&P TMI is designed to track the broad U.S. equity market. The pharmaceuticals segment of the S&P TMI comprises the following Global Industry Classification Standard (GICS®) sub-industry: pharmaceuticals.
Exposures
Index as of 9/30/2024
Sum of weightings may not equal 100% due to rounding. These percentages are allowed to fluctuate between semi-annual reconstitution dates and may be higher or lower than the indicated amounts until they are reset at the next Index reconstitution date.
Distributions
There is no guarantee that dividends or interest income will be paid.